Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 120

1.

Building one molecule from a reservoir of two atoms.

Liu LR, Hood JD, Yu Y, Zhang JT, Hutzler NR, Rosenband T, Ni KK.

Science. 2018 May 25;360(6391):900-903. doi: 10.1126/science.aar7797. Epub 2018 Apr 12.

PMID:
29650700
2.

Innovation in rural settings.

Cole EJ, Hood JD, Matthews D, Hobday TD.

Surgery. 2016 Dec;160(6):1432-1435. doi: 10.1016/j.surg.2016.08.001. Review. No abstract available.

PMID:
27866640
3.

Atom-atom interactions around the band edge of a photonic crystal waveguide.

Hood JD, Goban A, Asenjo-Garcia A, Lu M, Yu SP, Chang DE, Kimble HJ.

Proc Natl Acad Sci U S A. 2016 Sep 20;113(38):10507-12. doi: 10.1073/pnas.1603788113. Epub 2016 Aug 31.

4.

Regulatory and T Effector Cells Have Overlapping Low to High Ranges in TCR Affinities for Self during Demyelinating Disease.

Hood JD, Zarnitsyna VI, Zhu C, Evavold BD.

J Immunol. 2015 Nov 1;195(9):4162-70. doi: 10.4049/jimmunol.1501464. Epub 2015 Sep 18.

5.

Superradiance for Atoms Trapped along a Photonic Crystal Waveguide.

Goban A, Hung CL, Hood JD, Yu SP, Muniz JA, Painter O, Kimble HJ.

Phys Rev Lett. 2015 Aug 7;115(6):063601. Epub 2015 Aug 5.

PMID:
26296116
6.

Atom-light interactions in photonic crystals.

Goban A, Hung CL, Yu SP, Hood JD, Muniz JA, Lee JH, Martin MJ, McClung AC, Choi KS, Chang DE, Painter O, Kimble HJ.

Nat Commun. 2014 May 8;5:3808. doi: 10.1038/ncomms4808.

PMID:
24806520
7.

Enhancement of mechanical Q factors by optical trapping.

Ni KK, Norte R, Wilson DJ, Hood JD, Chang DE, Painter O, Kimble HJ.

Phys Rev Lett. 2012 May 25;108(21):214302. Epub 2012 May 21.

PMID:
23003262
8.

Insights into T cell recognition of antigen: significance of two-dimensional kinetic parameters.

Edwards LJ, Zarnitsyna VI, Hood JD, Evavold BD, Zhu C.

Front Immunol. 2012 Apr 20;3:86. doi: 10.3389/fimmu.2012.00086. eCollection 2012.

9.

Low 2-dimensional CD4 T cell receptor affinity for myelin sets in motion delayed response kinetics.

Rosenthal KM, Edwards LJ, Sabatino JJ Jr, Hood JD, Wasserman HA, Zhu C, Evavold BD.

PLoS One. 2012;7(3):e32562. doi: 10.1371/journal.pone.0032562. Epub 2012 Mar 7.

10.

'Exhaustive' look at PD-1/PDL-1 blockade in vivo.

Bozeman EN, Hood JD, Shashidharamurthy R, Selvaraj P.

Immunotherapy. 2009 Jul;1(4):525-7. doi: 10.2217/imt.09.37. No abstract available.

11.

Immunoprofiling toll-like receptor ligands: Comparison of immunostimulatory and proinflammatory profiles in ex vivo human blood models.

Hood JD, Warshakoon HJ, Kimbrell MR, Shukla NM, Malladi SS, Wang X, David SA.

Hum Vaccin. 2010 Apr;6(4):322-35. Epub 2010 Apr 7.

PMID:
20372068
12.

Potential adjuvantic properties of innate immune stimuli.

Warshakoon HJ, Hood JD, Kimbrell MR, Malladi S, Wu WY, Shukla NM, Agnihotri G, Sil D, David SA.

Hum Vaccin. 2009 Jun;5(6):381-94. Epub 2009 Jun 16. Review.

PMID:
19270494
13.

Decreased differentiation of erythroid cells exacerbates ineffective erythropoiesis in beta-thalassemia.

Libani IV, Guy EC, Melchiori L, Schiro R, Ramos P, Breda L, Scholzen T, Chadburn A, Liu Y, Kernbach M, Baron-Lühr B, Porotto M, de Sousa M, Rachmilewitz EA, Hood JD, Cappellini MD, Giardina PJ, Grady RW, Gerdes J, Rivella S.

Blood. 2008 Aug 1;112(3):875-85. doi: 10.1182/blood-2007-12-126938. Epub 2008 May 14.

14.

Comparison of the immunostimulatory and proinflammatory activities of candidate Gram-positive endotoxins, lipoteichoic acid, peptidoglycan, and lipopeptides, in murine and human cells.

Kimbrell MR, Warshakoon H, Cromer JR, Malladi S, Hood JD, Balakrishna R, Scholdberg TA, David SA.

Immunol Lett. 2008 Jun 30;118(2):132-41. doi: 10.1016/j.imlet.2008.03.009. Epub 2008 Apr 18.

15.

Selective inhibition of JAK2-driven erythroid differentiation of polycythemia vera progenitors.

Geron I, Abrahamsson AE, Barroga CF, Kavalerchik E, Gotlib J, Hood JD, Durocher J, Mak CC, Noronha G, Soll RM, Tefferi A, Kaushansky K, Jamieson CH.

Cancer Cell. 2008 Apr;13(4):321-30. doi: 10.1016/j.ccr.2008.02.017.

16.

Efficacy of TG101348, a selective JAK2 inhibitor, in treatment of a murine model of JAK2V617F-induced polycythemia vera.

Wernig G, Kharas MG, Okabe R, Moore SA, Leeman DS, Cullen DE, Gozo M, McDowell EP, Levine RL, Doukas J, Mak CC, Noronha G, Martin M, Ko YD, Lee BH, Soll RM, Tefferi A, Hood JD, Gilliland DG.

Cancer Cell. 2008 Apr;13(4):311-20. doi: 10.1016/j.ccr.2008.02.009.

17.

TG101348, a JAK2-selective antagonist, inhibits primary hematopoietic cells derived from myeloproliferative disorder patients with JAK2V617F, MPLW515K or JAK2 exon 12 mutations as well as mutation negative patients.

Lasho TL, Tefferi A, Hood JD, Verstovsek S, Gilliland DG, Pardanani A.

Leukemia. 2008 Sep;22(9):1790-2. doi: 10.1038/leu.2008.56. Epub 2008 Mar 20. No abstract available.

PMID:
18354492
18.

Development of prodrug 4-chloro-3-(5-methyl-3-{[4-(2-pyrrolidin-1-ylethoxy)phenyl]amino}-1,2,4-benzotriazin-7-yl)phenyl benzoate (TG100801): a topically administered therapeutic candidate in clinical trials for the treatment of age-related macular degeneration.

Palanki MS, Akiyama H, Campochiaro P, Cao J, Chow CP, Dellamary L, Doukas J, Fine R, Gritzen C, Hood JD, Hu S, Kachi S, Kang X, Klebansky B, Kousba A, Lohse D, Mak CC, Martin M, McPherson A, Pathak VP, Renick J, Soll R, Umeda N, Yee S, Yokoi K, Zeng B, Zhu H, Noronha G.

J Med Chem. 2008 Mar 27;51(6):1546-59. doi: 10.1021/jm7011276. Epub 2008 Feb 27.

PMID:
18311895
19.

Discovery of [7-(2,6-dichlorophenyl)-5-methylbenzo [1,2,4]triazin-3-yl]-[4-(2-pyrrolidin-1-ylethoxy)phenyl]amine--a potent, orally active Src kinase inhibitor with anti-tumor activity in preclinical assays.

Noronha G, Barrett K, Boccia A, Brodhag T, Cao J, Chow CP, Dneprovskaia E, Doukas J, Fine R, Gong X, Gritzen C, Gu H, Hanna E, Hood JD, Hu S, Kang X, Key J, Klebansky B, Kousba A, Li G, Lohse D, Mak CC, McPherson A, Palanki MS, Pathak VP, Renick J, Shi F, Soll R, Splittgerber U, Stoughton S, Tang S, Yee S, Zeng B, Zhao N, Zhu H.

Bioorg Med Chem Lett. 2007 Feb 1;17(3):602-8. Epub 2006 Nov 7.

PMID:
17113292
20.

Differential alphav integrin-mediated Ras-ERK signaling during two pathways of angiogenesis.

Hood JD, Frausto R, Kiosses WB, Schwartz MA, Cheresh DA.

J Cell Biol. 2003 Sep 1;162(5):933-43.

21.

Building a better Trap.

Hood JD, Cheresh DA.

Proc Natl Acad Sci U S A. 2003 Jul 22;100(15):8624-5. Epub 2003 Jul 14. No abstract available.

22.

Targeted delivery of mutant Raf kinase to neovessels causes tumor regression.

Hood JD, Cheresh DA.

Cold Spring Harb Symp Quant Biol. 2002;67:285-91. Review. No abstract available.

PMID:
12858551
23.

Role of Raf in vascular protection from distinct apoptotic stimuli.

Alavi A, Hood JD, Frausto R, Stupack DG, Cheresh DA.

Science. 2003 Jul 4;301(5629):94-6.

24.

Role of integrins in cell invasion and migration.

Hood JD, Cheresh DA.

Nat Rev Cancer. 2002 Feb;2(2):91-100. Review.

PMID:
12635172
25.

Tumor regression by targeted gene delivery to the neovasculature.

Hood JD, Bednarski M, Frausto R, Guccione S, Reisfeld RA, Xiang R, Cheresh DA.

Science. 2002 Jun 28;296(5577):2404-7.

26.

Src-mediated coupling of focal adhesion kinase to integrin alpha(v)beta5 in vascular endothelial growth factor signaling.

Eliceiri BP, Puente XS, Hood JD, Stupack DG, Schlaepfer DD, Huang XZ, Sheppard D, Cheresh DA.

J Cell Biol. 2002 Apr 1;157(1):149-60. Epub 2002 Apr 1.

27.

Selective requirement for Src kinases during VEGF-induced angiogenesis and vascular permeability.

Eliceiri BP, Paul R, Schwartzberg PL, Hood JD, Leng J, Cheresh DA.

Mol Cell. 1999 Dec;4(6):915-24.

28.

VEGF upregulates ecNOS message, protein, and NO production in human endothelial cells.

Hood JD, Meininger CJ, Ziche M, Granger HJ.

Am J Physiol. 1998 Mar;274(3 Pt 2):H1054-8.

PMID:
9530221
29.

Nitric oxide is an upstream signal of vascular endothelial growth factor-induced extracellular signal-regulated kinase1/2 activation in postcapillary endothelium.

Parenti A, Morbidelli L, Cui XL, Douglas JG, Hood JD, Granger HJ, Ledda F, Ziche M.

J Biol Chem. 1998 Feb 13;273(7):4220-6.

30.

The interaction of angular and linear optokinetic stimuli with an angular vestibular stimulus.

Mossman SS, Bronstein AM, Hood JD, Sacares P.

Ann N Y Acad Sci. 1992 May 22;656:868-70. No abstract available.

PMID:
1599204
31.

Stretch-activated single-channel and whole cell currents in vascular smooth muscle cells.

Davis MJ, Donovitz JA, Hood JD.

Am J Physiol. 1992 Apr;262(4 Pt 1):C1083-8.

PMID:
1373561
32.

Linear and angular optokinetic nystagmus in labyrinthine and central nervous system lesions.

Mossman SS, Bronstein AM, Hood JD.

Acta Otolaryngol Suppl. 1991;481:352-6. No abstract available.

PMID:
1927415
33.

A novel series of milbemycin antibiotics from Streptomyces strain E225. II. Isolation, characterization, structure elucidation and solution conformations.

Baker GH, Dorgan RJ, Everett JR, Hood JD, Poulton ME.

J Antibiot (Tokyo). 1990 Sep;43(9):1069-76. Erratum in: J Antibiot (Tokyo) 1991 May;44(5):C-2.

34.

Visual control of balance in cerebellar and parkinsonian syndromes.

Bronstein AM, Hood JD, Gresty MA, Panagi C.

Brain. 1990 Jun;113 ( Pt 3):767-79.

PMID:
2364268
35.
36.

The functional significance of auditory adaptation.

Hood JD.

Br J Audiol. 1990 Jun;24(3):151-4.

PMID:
2364185
37.
38.

A novel series of milbemycin antibiotics from Streptomyces strain E225. I. Discovery, fermentation and anthelmintic activity.

Hood JD, Banks RM, Brewer MD, Fish JP, Manger BR, Poulton ME.

J Antibiot (Tokyo). 1989 Nov;42(11):1593-8.

40.

Observations bearing upon semi-circular canal dynamics.

Hood JD, Marriage JE.

Exp Brain Res. 1989;74(3):603-8.

PMID:
2707335
41.

Transfer of optokinetic activity to vestibular nystagmus.

Barratt HJ, Hood JD.

Acta Otolaryngol. 1988 Mar-Apr;105(3-4):318-27.

PMID:
3260439
42.

Oscillopsia of peripheral vestibular origin. Central and cervical compensatory mechanisms.

Bronstein AM, Hood JD.

Acta Otolaryngol. 1987 Sep-Oct;104(3-4):307-14.

PMID:
3673562
43.

Hearing acuity and susceptibility to noise-induced hearing loss.

Hood JD.

Br J Audiol. 1987 Aug;21(3):175-81.

PMID:
3620752
44.

New perspectives in the investigation of disorders of balance.

Hood JD.

Br J Audiol. 1986 Aug;20(3):195-207.

PMID:
3488780
45.

The cervico-ocular reflex in normal subjects and patients with absent vestibular function.

Bronstein AM, Hood JD.

Brain Res. 1986 May 14;373(1-2):399-408.

PMID:
3487371
46.

Traumatic pneumocephalus caused by stab wound to the neck.

Naseem M, Hood JD, Devasthali R.

AJNR Am J Neuroradiol. 1986 Jan-Feb;7(1):174-5. No abstract available.

PMID:
3082135
47.

Observations upon the evoked responses to natural vestibular stimulation.

Hood JD, Kayan A.

Electroencephalogr Clin Neurophysiol. 1985 Jul;62(4):266-76.

PMID:
2408873
48.

Cervical nystagmus due to loss of cerebellar inhibition on the cervico-ocular reflex: a case report.

Bronstein AM, Hood JD.

J Neurol Neurosurg Psychiatry. 1985 Feb;48(2):128-31.

49.

Neuro-otological manifestations of migraine.

Kayan A, Hood JD.

Brain. 1984 Dec;107 ( Pt 4):1123-42.

PMID:
6334543
50.

Tonal adaptation.

Barratt H, Hood JD.

Br J Audiol. 1984 Nov;18(4):195-7.

PMID:
6525471

Supplemental Content

Support Center